Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

General Practice research publications

Puka rangahau

Other Research Output

Toop, L. (2014, September). Opportunities for integrated care and innovation after two decades of general practice/acute care reform: A New Zealand case study NHMRC Centre of Research Excellence Quality & Safety in Integrated Primary/Secondary Care Seminar, University of Queensland, Brisbane, Australia. [Department Seminar].

^ Top of page

Chapter in Book - Research

Mangin, D. (2016). The contribution of primary care research to improving health services. In F. Goodyear-Smith & B. Mash (Eds.), International perspectives on primary care research. (pp. 67-72). Boca Raton, FL: CRC Press.

Healy, D., & Mangin, D. (2016). Does my bias look big in this? In F. Baylis & A. Ballantyne (Eds.), Clinical research involving pregnant women. (pp. 197-208). Springer. doi: 10.1007/978-3-319-26512-4_11

Mangin, D. (2015). A primary care perspective on prescribing for women. In M. Harrison-Woolrych (Ed.), Medicines for women. (pp. 403-432). Springer.

^ Top of page

Journal - Research Article

Malihi, Z., Lawes, C. M. M., Wu, Z., Huang, Y., Waayer, D., Toop, L., … Scragg, R. (2019). Monthly high-dose vitamin D supplementation does not increase kidney stone risk or serum calcium: Results from a randomized controlled trial. American Journal of Clinical Nutrition. Advance online publication. doi: 10.1093/ajcn/nqy378

Currie, O., Williman, J., Mangin, D., McKinnon-Gee, B., & Bridgford, P. (2019). Comparative risk of new-onset diabetes following commencement of antipsychotics in New Zealand: A population-based clustered multiple baseline time series design. BMJ Open, 9(2), e022984. doi: 10.1136/bmjopen-2018-022984

Ailabouni, N., Mangin, D., & Nishtala, P. S. (2019). DEFEAT-polypharmacy: Deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. International Journal of Clinical Pharmacy. Advance online publication. doi: 10.1007/s11096-019-00784-9

Mangin, D., Lawson, J., Cuppage, J., Shaw, E., Ivanyi, K., Davis, A., & Risdon, C. (2018). Legacy drug-prescribing patterns in primary care. Annals of Family Medicine, 16(6), 515-520. doi: 10.1370/afm.2315

Malihi, Z., Lawes, C. M. M., Wu, Z., Huang, Y., Waayer, D., Toop, L., … Scragg, R. (2018). Monthly high-dose vitamin D3 supplementation and self-reported adverse events in a 4-year randomized controlled trial. Clinical Nutrition. Advance online publication. doi: 10.1016/j.clnu.2018.07.034

Win, S. S., Camargo, Jr, C. A., Khaw, K.-T., Lawes, C. M. M., Sluyter, J., Waayer, D., Toop, L., & Scragg, R. (2018). Cross-sectional associations of vitamin D status with asthma prevalence, exacerbations, and control in New Zealand adults. Journal of Steroid Biochemistry & Molecular Biology. Advance online publication. doi: 10.1016/j.jsbmb.2018.11.016

Scragg, R., Khaw, K.-T., Toop, L., Sluyter, J., Lawes, C. M. M., Waayer, D., … Camargo, Jr, C. A. (2018). Monthly high-dose vitamin D supplementation and cancer risk: A post hoc analysis of the Vitamin D Assessment Randomized Clinical Trial. JAMA Oncology. Advance online publication. doi: 10.1001/jamaoncol.2018.2178

Wu, Z., Camargo, Jr, C. A., Khaw, K.-T., Waayer, D., Lawes, C. M. M., Toop, L., & Scragg, R. (2018). Effects of vitamin D supplementation on adherence and persistence with long-term statin therapy: Secondary analysis from the randomized, double-blind, placebo-controlled ViDA study. Atherosclerosis. Advance online publication. doi: 10.1016/j.atherosclerosis.2018.04.009

Stairmand, J., Gurney, J., Stanley, J., Millar, E., Davies, C., Semper, K., Dowell, A., Mangin, D., Lawrenson, R., & Sarfati, D. (2018). The impact of multimorbidity on people's lives: A cross-sectional survey. New Zealand Medical Journal, 131(1477), 78-90. Retrieved from https://www.nzma.org.nz/journal

Wu, Z., Camargo, Jr, C. A., Sluyter, J. D., Khaw, K.-T., Malihi, Z., Waayer, D., Toop, L., … Scragg, R. (2018). Association between serum 25-hydroxyvitamin D levels and self-reported chronic pain in older adults: A cross-sectional analysis from the ViDA study. Journal of Steroid Biochemistry & Molecular Biology. Advance online publication. doi: 10.1016/j.jsbmb.2018.11.018

Rolston, C. J., Conner, T. S., Stamp, L. K., Neha, T., Pitama, S., Fanning, N., … Hudson, B., Hegarty, R. M., & Treharne, G. J. (2018). Improving gout education from patients’ perspectives: A focus group study of Māori and Pākehā people with gout. Journal of Primary Health Care, 10(3), 194-200. doi: 10.1071/HC18010

Darlow, B., Brown, M., Thompson, B., Hudson, B., Grainger, R., McKinlay, E., & Abbott, J. H. (2018). Living with osteoarthritis is a balancing act: An exploration of patients' beliefs about. BMC Rheumatology, 2, 15. doi: 10.1186/s41927-018-0023-x

Treharne, G. J., Richardson, A. C., Neha, T., Fanning, N., Janes, R., Hudson, B., … Pitama, S., & Stamp, L. K. (2018). Education preferences of people with gout: Exploring differences between indigenous and non-indigenous peoples from rural and urban locations. Arthritis Care & Research, 70(2), 260-267. doi: 10.1002/acr.23272

Wu, Z., Camargo, Jr, C. A., Malihi, Z., Bartley, J., Waayer, D., Lawes, C. M. M., Toop, L., … Scragg, R. (2018). Monthly vitamin D supplementation, pain, and pattern of analgesic prescription: Secondary analysis from the randomized, double-blind, placebo-controlled Vitamin D Assessment study. Pain, 159(6), 1074-1082. doi: 10.1097/j.pain.0000000000001189

Sluyter, J. D., Camargo, Jr, C. A., Waayer, D., Lawes, C. M. M., Toop, L., Khaw, K. T., & Scragg, R. (2017). Effect of monthly, high-dose, long-term vitamin D on lung function: A randomized controlled trial. Nutrients, 9(12), 1353. doi: 10.3390/nu9121353

Signal, L., Semper, K., Stairmand, J., Davies, C., Millar, E., Dowell, T., … Mangin, D., & Sarfati, D. (2017). A walking stick in one hand and a chainsaw in the other: Patients’ perspectives of living with multimorbidity. New Zealand Medical Journal, 130(1455), 65-76. Retrieved from https://www.nzma.org.nz/journal

Ailabouni, N., Mangin, D., & Nishtala, P. S. (2017). Can deprescribing give what polypharmacy has taken away? Feasibility trial in residential aged care. Innovation in Aging, 1(Suppl. 1), 588-589. doi: 10.1093/geroni/igx004.2065

Khaw, K.-T., Stewart, A. W., Waayer, D., Lawes, C. M. M., Toop, L., Camargo, Jr, C. A., & Scragg, R. (2017). Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: Secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial. Lancet Diabetes & Endocrinology, 5(6), 438-447. doi: 10.1016/S2213-8587(17)30103-1

Scragg, R., Stewart, A. W., Waayer, D., Lawes, C. M. M., Toop, L., Sluyter, J., … Camargo, Jr, C. A. (2017). Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the Vitamin D Assessment Study: A randomized clinical trial. JAMA Cardiology, 2(6), 608-616. doi: 10.1001/jamacardio.2017.0175

Bagshaw, P., Bagshaw, S., Frampton, C., Gauld, R., Green, T., Harris, C., Hornblow, A., Hudson, B., … Toop, L. (2017). Pilot study of methods for assessing unmet secondary health care need in New Zealand. New Zealand Medical Journal, 130(1452), 23-38. Retrieved from https://www.nzma.org.nz/journal

Ailabouni, N., Mangin, D., Tordoff, J. M., & Nishtala, P. S. (2017). Do my patients need all their medicines? Registered nurses' views on deprescribing. Innovation in Aging, 1(Suppl. 1), 571. doi: 10.1093/geroni/igx004.2009

Sluyter, J. D., Camargo, Jr, C. A., Stewart, A. W., Waayer, D., Lawes, C. M. M., Toop, L., … Scragg, R. (2017). Effect of monthly, high-dose, long-term vitamin D supplementation on central blood pressure parameters: A randomised controlled trial substudy. Journal of the American Heart Association, 6, e006802. doi: 10.1161/JAHA.117.006802

Christie, C., Bidwell, S., Copeland, A., & Hudson, B. (2017). Self-care of Canterbury general practitioners, nurse practitioners, practice nurses and community pharmacists. Journal of Primary Health Care, 9(4), 286-291. doi: 10.1071/HC17034

Siu, H. Y.-H., Mangin, D., Howard, M., Price, D., & Chan, D. (2017). Developing and testing an electronic medication administration monitoring device for community dwelling seniors: A feasibility study. Pilot & Feasibility Studies, 3(1), 5. doi: 10.1186/s40814-016-0118-3

Ailabouni, N., Tordoff, J., Mangin, D., & Nishtala, P. S. (2017). Do residents need all their medications? A cross-sectional survey of RNs' views on deprescribing and the role of clinical pharmacists. Journal of Gerontological Nursing, 43(10), 13-20. doi: 10.3928/00989134-20170914-05

Ailabouni, N., Mangin, D., & Nishtala, P. S. (2017). Deprescribing anticholinergic and sedative medicines: Protocol for a feasibility trial (DEFEAT-polypharmacy) in residential aged care facilities. BMJ Open, 7(4), e013800. doi: 10.1136/bmjopen-2016-013800

Healy, D., Le Noury, J., & Mangin, D. (2016). Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence. International Journal of Risk & Safety in Medicine, 28(3), 125-141. doi: 10.3233/JRS-160726

Maggo, S. D. S., Savage, R. L., & Kennedy, M. A. (2016). Impact of new genomic technologies on understanding adverse drug reactions. Clinical Pharmacokinetics, 55(4), 419-436. doi: 10.1007/s40262-015-0324-9

Dolovich, L., Oliver, D., Lamarche, L., Agarwal, G., Carr, T., Chan, D., … Mangin, D., … Price, D. (2016). A protocol for a pragmatic randomized controlled trial using the Health Teams Advancing Patient Experience: Strengthening Quality (Health TAPESTRY) platform approach to promote person-focused primary healthcare for older adults. Implementation Science, 11, 49. doi: 10.1186/s13012-016-0407-5

Ailabouni, N. J., Nishtala, P. S., Mangin, D., & Tordoff, J. M. (2016). Challenges and enablers of deprescribing: A general practitioner perspective. PLoS ONE, 11(4), e0151066. doi: 10.1371/journal.pone.0151066

Mangin, D., Stephen, G., Bismah, V., & Risdon, C. (2016). Making patient values visible in healthcare: A systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity. BMJ Open, 6(6), e010903. doi: 10.1136/bmjopen-2015-010903

Ailabouni, N. J., Nishtala, P. S., Mangin, D., & Tordoff, J. M. (2016). General practitioners' insight into deprescribing for the multimorbid older individual: A qualitative study. International Journal of Clinical Practice, 70(3), 261-276. doi: 10.1111/ijcp.12780

Scragg, R., Waayer, D., Stewart, A. W., Lawes, C. M. M., Toop, L., Murphy, J., … Camargo, Jr, C. A. (2015). The Vitamin D Assessment (ViDA) Study: Design of a randomized controlled trial of vitamin D supplementation for the prevention of cardiovascular disease, acute respiratory infection, falls and non-vertebral fractures. Journal of Steroid Biochemistry & Molecular Biology, 164, 318-325. doi: 10.1016/j.jsbmb.2015.09.010

Mangin, D., & Heath, I. (2015). Multimorbidity and quaternary prevention (P4). Revista Brasileira de Medicina de Família e Comunidade [Brazilian Journal of Family and Community Medicine], 10(35), 1-5. doi: 10.5712/rbmfc10(35)1069

Savage, R. L., Zekarias, A., & Caduff-Janosa, P. (2015). Varenicline and abnormal sleep related events. Sleep, 38(5), 833-837. doi: 10.5665/sleep.4686

Barthow, C., Jones, B., Macdonald, L., Vernall, S., Gallagher, P., & McKinlay, E. (2015). Researching in the community: The value and contribution of nurses to community based or primary health care research. Primary Health Care Research & Development, 16, 224-234. doi: 10.1017/s1463423614000097

Cook, L. A., Pun, A., Gallo, M. F., Lopez, L. M., & Van Vliet, H. A. A. M. (2014). Scalpel versus no-scalpel incision for vasectomy (Review). Cochrane Database of Systematic Reviews, 3, CD004112. doi: 10.1002/14651858.CD004112.pub4

Parker, J. E., Hudson, B., & Wilkinson, T. J. (2014). Influences on final year medical students' attitudes to general practice as a career. Journal of Primary Health Care, 6(1), 56-63.

Cook, L. A., Van Vliet, H. A. A. M., Lopez, L. M., Pun, A., & Gallo, M. F. (2014). Vasectomy occlusion techniques for male sterilization (Review). Cochrane Database of Systematic Reviews, 3, CD003991. doi: 10.1002/14651858.CD003991.pub4

Healy, D., Howe, G., Mangin, D., & Le Noury, J. (2014). Sudden cardiac death & the reverse Dodo verdict. International Journal of Risk & Safety in Medicine, 26(2), 71-79. doi: 10.3233/JRS-140615

Brookwell, L., Hogan, C., Healy, D., & Mangin, D. (2014). Ninety-three cases of alcohol dependence following SSRI treatment. International Journal of Risk & Safety in Medicine, 26(2), 99-107. doi: 10.3233/JRS-140616

Hogan, C., Le Noury, J., Healy, D., & Mangin, D. (2014). One hundred and twenty cases of enduring sexual dysfunction following treatment. International Journal of Risk & Safety in Medicine, 26(2), 109-116. doi: 10.3233/JRS-140617

^ Top of page

Journal - Research Other

Townsend, P., Toop, L., Aish, H., Jordan, L., & Cullen, F. (2019). Response to 'Elephants in the room" editorial, 1 February 2019. New Zealand Medical Journal, 132(1495), 86-87. Retrieved from http://www.nzma.org.nz/journal

Duffy, L., Bacon, F., Clarke, C. S., Donkor, Y., Freemantle, N., Gilbody, S., … Mangin, D., … Lewis, G. (2019). A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): Study protocol for a randomised controlled trial. Trials, 20(1), 319. doi: 10.1186/s13063-019-3390-8

Savage, R. L., & Tatley, M. V. (2018). Case series analysis of New Zealand reports of rapid intense potentiation of warfarin by roxithromycin [Short communcation]. Drug Safety, 41(5), 515-521. doi: 10.1007/s40264-017-0634-y

Millar, E., Dowell, A., Lawrenson, R., Mangin, D., & Sarfati, D. (2018). Clinical guidelines: What happens when people have multiple conditions? New Zealand Medical Journal, 131(1472), 73-81. Retrieved from https://www.nzma.org.nz/journal

Toop, L. (2017). Steps towards more integrated care in New Zealand: A general practice perspective. BJGP Open, 1(1), 0845. doi: 10.3399/bjgpopen17X100845

Lunt, H., & Hudson, B. (2017). Metformin: A golden oldie. New Zealand Medical Journal, 130(1465), 9-11. Retrieved from http://www.nzma.org.nz/journal

Swinburn, B., Vandevijvere, S., on behalf of submitting health professors, including Hornblow, A., Taylor, B., Drummond, B., Murdoch, D., Mangin, D., Sarfati, D., Sellman, D., Sopoaga, F., Thomson, G., Abel, G., Hoek, J., Connor, J., Krebs, J., Mann, J., McCall, J., Broughton, J., Toop, L., Signal, L., Beckert, L., Farella, M., Baker, M., Keall, M., Skeaff, M., Thomson, M., Wilson, N., Chandler, N., Priest, P., Brunton, P., Crampton, P., Gendall, P., Howden-Chapman, P., Taylor, R., Edwards, R., Gauld, R., McGee, R., Mulder, R., Derrett, S., Hales, S., Pullon, S., & Blakely, T. (2017). Proposed new industry code on unhealthy food marketing to children and young people: Will it make a difference? New Zealand Medical Journal, 130(1450), 94-101. Retrieved from http://www.nzma.org.nz/journal

Savage, R. L., Castellano, M., & Tatley, M. V. (2017). International reports of unexpected low plasma concentrations of dabigatran suggest that more frequent measurements will add value. Seminars in Thrombosis & Hemostasis, 43(6), 635-638. doi: 10.1055/s-0037-1603361

Savage, R. (2016). Vemurafenib and atrial fibrillation: Signal strengthening. WHO Pharmaceuticals Newsletter, 1, 17-22. Retrieved from http://www.who.int/medicines/publications/newsletter/en/

Mulder, R., Rucklidge, J. J., & Toop, L. (2016). Restoring Study 329: Paroxetine neither effective nor safe for adolescents. Australian & New Zealand Journal of Psychiatry, 50(9), 922-923. doi: 10.1177/0004867416657412

Castellano, M., Sartori, D., & Savage, R. (2016). Dabigatran and thromboembolism: Analysis of case histories for risk factors. WHO Pharmaceuticals Newsletter, 3, 15-22. Retrieved from http://www.who.int/medicines/publications/newsletter/en/

Savage, R. (2015). Brentuximab and hepatic disorders. WHO Pharmaceuticals Newsletter, 2, 17-22. Retrieved from http://www.who.int/medicines/publications/PharmaNewsletter2_15/en/

Birtwhistle, R., Barber, D., Drummond, N., Godwin, M., Greiver, M., Singer, A., … Mangin, D. (2015). Horses and buggies have some advantages over cars, but no one is turning back. Canadian Family Physician, 61(5), 416-418. [Letter].

Toop, L., & Mangin, D. (2015). The art and science of marketing medications. New Zealand Medical Journal, 128(1421). Retrieved from https://www.nzma.org.nz/journal

Currie, O. (2015). Ageing positively for New Zealanders. Journal of Primary Health Care, 7(4), 268. [Editorial].

Hudson, B., Williman, J. A., Stamp, L. K., Alchin, J. S., Hooper, G. J., Mangin, D., Thompson, B. F., & Toop, L. (2015). Nortriptyline in knee osteoarthritis (NortIKA Study): Study protocol for a randomised controlled trial. Trials, 16, 448. doi: 10.1186/s13063-015-0961-1

Wells, J. E., Cross, N. B., Savage, R. L., Parkin, L., Horsburgh, S., & Richardson, A. K. (2015). Renal replacement therapy associated with lithium nephrotoxicity in New Zealand. New Zealand Medical Journal, 128(1425). Retrieved from http://www.nzma.org.nz/journal

Toop, L., & Jackson, C. (2015). Patient co-payment for general practice services: Slippery slope or a survival imperative for the NHS? British Journal of General Practice, 65(635), 276-277. doi: 10.3399/bjgp15X685105

Hoffmann, T. C., Légaré, F., Simmons, M. B., McNamara, K., McCaffery, K., Trevena, L. J., Hudson, B., & Glaszlou, P. P. (2014). Shared decision making: What do clinicians need to know and why should they bother? Medical Journal of Australia, 201(1), 35-39. doi: 10.5694/mja14.00002

Healy, D., Mangin, D., & Applbaum, K. (2014). The shipwreck of the singular. Social Studies of Science, 44(4), 518-523. doi: 10.1177/0306312714536270

Savage, R. (2014). Tocilizumab: Psoriasis and aggravated psoriasis. WHO Pharmaceuticals Newsletter, 2, 16-21. Retrieved from http://www.who.int/medicines/publications/PharmNewsletter2_14/en/

da Silva, A. L., Mangin, D., Pizzanelli, M., Jamoulle, M., Wagner, H. L., De Silva, D. H. S., … Júnior, W. R. (2014). Manifesto de Curitaba: pela Prevenção Quaternária e por uma Medicin sem conflitos de interesse [The Curitiba Manifesto: for the quaternary prevention and for a medical practice without conflicts of interest. Revista Brasileira de Medicina de Família e Comunidade [Brazilian Journal of Family and Community Medicine], 9(33), 371-374. doi: 10.5712/rbmfc9(33)1006

Mangin, D. (2014). Ethical issues related to health checks. BMJ, 349, g4787. doi: 10.1136/bmj.g4787

^ Top of page

Journal - Professional & Other Non-Research Articles

Bagshaw, P., & Hudson, B. (2018). Unmet health-care need. Journal of Primary Health Care, 10(2), 179-180. doi: 10.1071/HC18009

^ Top of page

Conference Contribution - Published proceedings: Abstract

Darlow, B., Brown, M., Lennox Thompson, B., Hudson, B., Grainger, R., McKinlay, E., & Abbott, H. (2018). Living with osteoarthritis is a balancing act: An exploration of beliefs about knee pain in people with osteoarthritis. Proceedings of the Physiotherapy New Zealand Conference. (pp. 53-54). Retrieved from https://pnz.org.nz/conference

Stamp, L. K., Chapman, P. T., Hudson, B., Hamilton, G., & Judd, A. (2018). The challenges of managing gout in primary care: Results of a best practice audit. Arthritis & Rheumatology, 70(9, Suppl.), 1265. doi: 10.1002/art.40700

Stamp, L., Chapman, P., Hudson, B., Hamilton, G., & Judd, A. (2018). The challenges of managing gout in primary care: Results of a best practice audit. Scandinavian Journal of Rheumatology, 47(Suppl. 129), (pp. 6). doi: 10.1080/03009742.2018.1487639

Currie, O., Mangin, D., & Williman, J. (2017). What do GPs care about when it comes to pharmacoepidemiology? Proceedings of the Primary Health Care and General Practice Research Weekend. Retrieved from http://www.otago.ac.nz/wellington/departments/primaryhealthcaregeneralpractice/research/

Darlow, B., Brown, M., Lennox Thompson, B., Hudson, B., Abbott, J., McKinlay, E., & Grainger, R. (2017). Walking a fine line (carefully): An exploration of beliefs about knee pain in people with osteoarthritis. Internal Medicine Journal, 47(Suppl. 2), (pp. 11). doi: 10.1111/imj.13426

Cuppage, J., Mangin, D., Lawson, J., Ivanyi, K., Shaw, E., & Risdon, C. (2017). Legacy drug prescribing patterns and associations in primary care: Cohort study in the MUSIC Practice Based Research Network. Proceedings of the North American Primary Care Research Group (NAPCRG) 45th Annual Meeting. P332. Retrieved from http://www.napcrg.org

Dolovich, L., Lamarche, L., Agarwal, G., Carr, T., Foster, G., Griffith, L., … Mangin, D., … Price, D. (2017). A pragmatic randomized controlled trial using the health teams advancing patient experience: Strengthening quality (Health TAPESTRY) approach to promote person-focused primary healthcare for older adults. Proceedings of the North American Primary Care Research Group (NAPCRG) 45th Annual Meeting. HH28. Retrieved from http://www.napcrg.org

Peter, J., Agarwal, G., Letts, L., Liddy, C., Mangin, D., O'Reilly, D., … Dolovich, L. (2017). A feasibility randomised controlled trial of a complex intervention for supporting patients with multiple chronic conditions in the self-management of their health. Proceedings of the North American Primary Care Research Group (NAPCRG) 45th Annual Meeting. MY33. Retrieved from http://www.napcrg.org

Darlow, B., Hudson, B., McKinlay, E., Brown, M., Thompson, B., Abbott, H., & Grainger, R. (2017). Walking a fine line (carefully): An exploration of beliefs about knee pain in people with osteoarthritis. Proceedings of the Primary Health Care and General Practice Research Weekend. Retrieved from http://www.otago.ac.nz/wellington/departments/primaryhealthcaregeneralpractice/research/

Stairmand, J., Signal, L., Semper, K., Davies, C., Millar, E., Dowell, T., … Mangin, D., & Sarfati, D. (2017). A walking stick and a chainsaw: Patients' perspectives of living with multimorbidity. Proceedings of the 15th World Congress on Public Health. Retrieved from https://wcph2017.entegyapp.com/Page/28/511/26/1459

Nicholson, K., Griffith, L., Raina, P., Fortin, M., Mangin, D., Terry, A., & Williamson, T. (2017). Therapeutic competition and ageing phenotypes of multimorbidity in Canada. Proceedings of the North American Primary Care Research Group (NAPCRG) 45th Annual Meeting. SRF161. Retrieved from http://www.napcrg.org

Savage, R., & Tatley, M. (2017). Rapid onset of very high INR values when roxithromycin prescribed with warfarin challenges the accepted mechanism. Drug Safety, 40(10), (pp. 963-964). doi: 10.1007/s40264-017-0580-8

Peter, J., Agarwal, G., Oliver, D., Valaitis, R., Richardson, J., Ploeg, J., Mangin, D., … Dolovich, L. (2016). Exploration of the effects of the Health Teams Advancing Patient Experience: Strengthening Quality with Health Connectors for Diabetes Management (Health TAPESTRY-HC-DM) program on volunteers. Proceedings of the North American Primary Care Research Group (NAPCRG) 44th Annual Meeting. DE25. Retrieved from http://www.napcrg.org

Garfinkel, D., & Mangin, D. (2016). "We should treat the patients - Not their numbers..." How to fight polypharmacy and reduce IMU in your own practice/clinic? [IGRIMUP Workshop]. Proceedings of the WONCA Europe Conference: Family Doctors with Head and Hearts. W77. Retrieved from http://www.woncaeurope2016.com/

Tatley, M., Savage, R., Kunac, D., & Ashton, J. (2016). Years of pharmacovigilance in New Zealand: Lessons in sustainability and growth. Drug Safety, 39(10), (pp. 1001). doi: 10.1007/s40264-016-0445-6

Mangin, D., Dowson, C., Mulder, R., Wells, E., Toop, L., Dowell, T., & Arroll, B. (2016). Can't fight this feeling? When and how to stop antidepressants [Invited]. Proceedings of the Royal New Zealand College of General Practitioners (RNZCGP) Conference for General Practice. Retrieved from http://www.generalpractice.org.nz/gp16

Savage, R., Star, K., Zekarias, A., Persson Brobert, G., Ansell, D., & Edwards, I. R. (2016). Prescribing and diagnostic issues associated with sumatriptan identified through open-ended screening for safety signals in electronic health care records. Drug Safety, 39(10), (pp. 1014-1015). doi: 10.1007/s40264-016-0445-6

Dolovich, L., Oliver, D., Larmarche, L., Foster, G., Griffith, L., Valaitis, R., Mangin, D., … Price, D. J. (2016). Health goals and needs identified in older adults and resultant actions taken after using the Health TAPESTRY volunteer and technology enabled interprofessional team based care platform. Proceedings of the North American Primary Care Research Group (NAPCRG) 44th Annual Meeting. GR33. Retrieved from http://www.napcrg.org

Valaitis, R., Dolovich, L., Ploeg, J., Risdon, C., Agarwal, G., Oliver, D., Mangin, D., … Cleghorn, L. (2016). Evolving structures and processes: Interprofessional teamwork and the implementation of Health TAPESTRY. Proceedings of the North American Primary Care Research Group (NAPCRG) 44th Annual Meeting. PR25. Retrieved from http://www.napcrg.org

Toop, L. (2016). Introducing desirable system-wide quality indicators to incentivise integration across and beyond the health system, using alliances led by primary care [Workshop]. Proceedings of the WONCA Europe Conference: Family Doctors with Head and Hearts. W88. Retrieved from http://www.woncaeurope2016.com/

Savage, R., Clark, P., & Tatley, M. (2016). Taking a fresh look at identifying and responding to drug-induced illness. Proceedings of the Royal New Zealand College of General Practitioners (RNZCGP) Conference for General Practice. Retrieved from http://www.generalpractice.org.nz/gp16

Ailabouni, N. J., Nishtala, P. S., Mangin, D., & Tordoff, J. (2015). Deprescribing feasibility study in New Zealand residential care homes. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting: Drugs to Medicines: Up Close and Personal. 400. Retrieved from http://www.asceptasm.com/

Mangin, D. (2015). The Antidepressant Cessation Trial study: Maintenance vs gradual withdrawal of fluoxetine in stable depression. Irish Ageing Studies Review, 6(1), 0931, (pp. 114). [Abstract]

Bagshaw, P., Shaw, C., Raymont, A., Richardson, A., Hornblow, A., Bagshaw, S., Frampton, C., Toop, L., & Gauld, R. (2015). The Canterbury Charity Hospital Trust and a pilot study to measure unmet elective healthcare need in New Zealand. Proceedings of the Royal New Zealand College of General Practitioners (RNZCGP) Conference for General Practice: Imagine: Inspire: Innovate. Retrieved from http://www.generalpractice.org.nz/gp15

Savage, R., & Tatley, M. (2015). Comparison of New Zealand and international spontaneous reports of adverse reactions occurring within one week of zoledronic acid infusion with the information in New Zealand product data sheets. In J. Young (Ed.), Proceedings of the Annual General Practice and Primary Care Research Weekend. (pp. 27-28). Dunedin, New Zealand: Department of General Practice and Rural Health, University of Otago. [Abstract]

Mangin, D. (2015). Commercial influence on healthcare and its influence on polypharmacy. Irish Ageing Studies Review, 6(1), 0930, (pp. 114). [Abstract]

Mangin, D., Dowson, C., Mulder, R., Wells, E., Toop, L., Dowell, T., & Arroll, B. (2015). The effectiveness of maintenance SSRI treatment in primary care depression to prevent recurrence: Multicentre double blinded placebo controlled RCT. Proceedings of the North American Primary Care Research Group (NAPCRG) 43rd Annual Meeting. Retrieved from http://www.napcrg.org/Conferences

Mangin, D., Dowson, C., Fergusson, D., & Wells, E. (2015). Does iron deficiency without anemia in infancy affect long term developmental outcomes? Prospective 6 year cohort study. Proceedings of the North American Primary Care Research Group (NAPCRG) 43rd Annual Meeting. Retrieved from http://www.napcrg.org/Conferences

Mangin, D. (2015). Pay for performance (P4), targets and polypharmacy. Irish Ageing Studies Review, 6(1), 0927, (pp. 114). [Abstract]

Ailabouni, N., Nishtala, P. S., Mangin, D., & Tordoff, J. (2015). Deprescribing: An insight into general practitioners' views on deprescribing for older patients. Proceedings of the New Zealand Hospital Pharmacists' Association (NZHPA) Annual Conference. (pp. 44). Retrieved from http://www.nzhpa.org.nz/conferences--meetings.aspx

Mangin, D. (2015). How to involve patients in de-prescribing. Irish Ageing Studies Review, 6(1), 0932, (pp. 114-115). [Abstract]

Currie, O. (2014). Use of electronic prescription database to assess risk of new onset diabetes after drugs are prescribed for cardiovascular risk: A study. Proceedings of the Royal New Zealand College of General Practitioners (RNZCGP) Conference for General Practice: Making Connections: Are You Plugged In? Retrieved from http://www.conference.co.nz/gp14/programme

Savage, R. L., Zekarias, A., & Caduff-Janosa, P. (2014). Varenicline and abnormal sleep-related events. Drug Safety, 37(10), (pp. 878-879). doi: 10.1007/s40264-014-0208-1

Toop, L., Hudson, B., & Alderton, A. (2014). Overdiagnosis and dangerous overtreatment of irritable infants with "reflux." A rapidly emerging non illness with a case study of an effective multi modal educational solution. Proceedings of the Second Preventing Overdiagnosis Conference. (pp. 34). Retrieved from http://www.preventingoverdiagnosis.net/

Jun, A., Richardson, A., & Toop, L. (2014). Supporting patients in decision-making and the challenges associated with this. Proceedings of the Royal New Zealand College of General Practitioners (RNZCGP) Conference for General Practice: Making Connections: Are You Plugged In? Retrieved from http://www.conference.co.nz/gp14/programme

Hudson, B. (2014). CVDRA & shared decision making. Proceedings of the Royal New Zealand College of General Practitioners (RNZCGP) Conference for General Practice: Making Connections: Are You Plugged In? Retrieved from http://www.conference.co.nz/gp14/programme

Hudson, B. (2014). Screening for prostate cancer in New Zealand: A policy to increase overdiagnosis: A cautionary tale and a proposal to avoid similar failures. Proceedings of the Second Preventing Overdiagnosis Conference. (pp. 44). Retrieved from http://www.preventingoverdiagnosis.net/

Mangin, D., Hoffman, M., Lundgren, C., & Trimble, J. (2014). Dangerous caring: Examining drivers for overtreatment and its consequences, evidence from interventions to counteract this, discussion of potential solutions at policy and clinical levels and how involvement of patients and families might facilitate change [Workshop]. Proceedings of the Second Preventing Overdiagnosis Conference. (pp. 4). Retrieved from http://www.preventingoverdiagnosis.net/

^ Top of page

Conference Contribution - Verbal presentation and other Conference outputs

Smith, J., Toop, L., Phillips, B., & Chong, P.-N. (2018, March). Moving care from hospital to community: International experience and policy drivers. Plenary presentation at the 4th International Health Care Reform Conference: Moving Care from Hospital to Community: Navigating the Bumps, Sydney, Australia.

Hudson, B., Williman, J. A., Stamp, L. K., Alchin, J. S., Hooper, G. J., Mangin, D., Thompson, B. F., & Toop, L. (2018, September). Nortriptyline in knee osteoarthritis (NortIKA Study): A randomised controlled trial. Verbal presentation at the General Practice and Primary Care Research Weekend, Hanmer Springs, New Zealand.

Mann, B. (2018, August). Diagnosis and managing somatising patients in the 15 minute consulation. Workshop presentation at the 9th South General Practice Conference & Medical Exhibition (GP CME), Christchurch, New Zealand.

Doogue, M., Chin, P., Simpson, C., Frew, G., Hudson, B., & Heppenstall, C. (2018, August). Recording adverse drug reactions in New Zealand. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

Goodwin, N., Osborn, R., Toop, L., & Jackson, C. (2018, March). 20 years in the care integration business: Turning talk into outcomes. Verbal presentation at the 4th International Health Care Reform Conference: Moving Care from Hospital to Community: Navigating the Bumps, Sydney, Australia.

Savage, R., Tatley, M., & Kunac, D. (2017, July). Fifty years of adverse drug reaction reporting in New Zealand: Primary care involvement and the developing use of e-health. Verbal presentation at the Royal New Zealand College of General Practitioners (RNZCGP) Conference for General Practice Quality Symposium, Dunedin, New Zealand.

Toop, L. (2017, May). Unpicking the 'Health Care Home model': How is it being described and implemented in New Zealand (and overseas). Verbal presentation at the Metro North Health Forum GP Breakfast Briefing, Brisbane, Australia.

Toop, L. (2017, May). Unpicking the 'Health Care Home model': How is it being described and implemented in New Zealand (and overseas). Keynote presentation at the Metro North Health Forum, Brisbane, Australia.

Toop, L. (2017, March). How quality development in general practice got on the agenda: The story of Pegasus Health, a New Zealand GP Network. Keynote presentation at the Aarhus University General Practice Research Unit 25th Anniversary Conference, Aarhus, Denmark.

Toop, L. (2017, October). Using QI measurements of whole system performance to incentivise collaboration [Invited]. Workshop presentation at the Royal College of General Practitioners (RCGP) Annual Primary Care Conference & Exhibition, Liverpool, UK.

Toop, L. (2016, July). We're here for our patients" So who are "we"? Where and when is "here? And what do "our patients" need, want and expect of us and why? How could or should we respond? A view from the middle. Verbal presentation at the Royal New Zealand College of General Practitioners (RNZCGP) Conference for General Practice Quality Symposium, Auckland, New Zealand.

Toop, L. (2016, August). Managing variation in Meso-level networks. Verbal presentation at the Health Quality & Safety Commission New Zealand Open Forum: Variation: The Good, the Bad and the Inexplicable, Wellington, New Zealand.

Toop, L. (2016, July). Learning to learn from the non-compliant: Patient common sense and experience is generally well ahead of the evidence, and often much safer. Verbal presentation at the Royal New Zealand College of General Practitioners (RNZCGP) Conference for General Practice, Auckland, New Zealand.

Toop, L. (2016, March). Health reform ownership: Top down or ground up?Lessons from two decades of innovation and quality improvement through education and partnership. Verbal presentation at the 3rd International Primary Health Care Reform Conference: Creating Value: But for Whom? Brisbane, Australia.

Hudson, B. (2016, July). Over diagnosis: Too much medicine. Workshop presentation at the Royal New Zealand College of General Practitioners (RNZCGP) Conference for General Practice, Auckland, New Zealand.

Malhi, G., Glue, P., Roy, H., Menkes, D., Jureidini, J., & Toop, L. (2016, October). This house believes that the pharmaceutical industry does more good than harm in the ongoing development and promotion of treatments in psychiatry [Debate]. Invited presentation at the Royal Australian & New Zealand College of Psychiatrists New Zealand Conference: Recover, Rebuild, Regenerate, Christchurch, New Zealand.

Mangin, D. (2015, February). Dangerous Caring. Workshop presentation at the Thompson Region Division of Family Practice Medicine Sun Peaks CME: Navigating the Practice Maze, Sun Peaks, BC, Canada.

Toop, L. (2015, July-August). Antibiotic prescribing and resistance, and the GP-patient relationship. Verbal presentation at the Royal New Zealand College of General Practitioners (RNZCGP) Conference for General Practice: Imagine: Inspire: Innovate, Hamilton, New Zealand.

Mangin, D. (2015, February). Sacred Monsters. Workshop presentation at the Thompson Region Division of Family Practice Medicine Sun Peaks CME: Navigating the Practice Maze, Sun Peaks, BC, Canada.

Mangin, D. (2015, April). Doing nothing, well: How good medicine can be bad for your patient's health (and how to avoid it). Keynote presentation at the Society of Rural Physicians of Canada 23rd Annual Rural and Remote Medicine Course: Innovation in Practice, Teaching and Research, Montreal, Canada.

Toop, L. (2015, March). Weighing the benefits and harms of guidelines and pathways as we move towards a more integrated health system. Verbal presentation at the Guidelines and Pathways Symposium, Wellington, New Zealand.

Dowell, T., & Toop, L. (2015, July-August). "It's a wrap". Panel discussion at the Royal New Zealand College of General Practitioners (RNZCGP) Conference for General Practice: Imagine: Inspire: Innovate, Hamilton, New Zealand.

Mangin, D. (2015, June). Patient reporting of drug adverse events. Plenary presentation at the International Society of Drug Bulletins (ISBD) General Assembly, Pamplona, Spain.

Mangin, D. (2015, April). Polypharmacy: Practical approaches in primary care. Verbal presentation at the Society of Rural Physicians of Canada 23rd Annual Rural and Remote Medicine Course: Innovation in Practice, Teaching and Research, Montreal, Canada.

Toop, L., Alderton, A., & Hudson, B. (2015, August). Overdiagnosis and dangerous overtreatment of irritable infants with "reflux". Verbal presentation at the George Abbott Symposium, Christchurch, New Zealand.

Hendry, A., Gerard, C., & Toop, L. (2015, July). Managing poly-pharmacy. Panel discussion at the Royal New Zealand College of General Practitioners (RNZCGP) Conference for General Practice Quality Symposium, Hamilton, New Zealand.

Toop, L., Kenealy, J., & Bevan, H. (2014, September). Targets: Survive or thrive? Do they help or do they hinder? Verbal presentation at the 3rd APAC Forum, Melbourne, Australia.

Toop, L., Baker, M., & Howe, A. (2014, July). Developing leadership and inspiring followers. Verbal presentation at the Royal New Zealand College of General Practitioners (RNZCGP) Conference for General Practice: Making Connections: Are You Plugged In? Christchurch, New Zealand.

Toop, L. (2014, July). Any quality outcome measure that requires a financial incentive to be accepted has a price but no value and should be banned [Dangerous ideas soapbox]. Verbal presentation at the Society for Academic Primary Care (SAPC) Conference, Edinburgh, Scotland.

Mangin, D. (2014, February). Disease mongering and de-prescribing. Verbal presentation at the Clinical Advisory Pharmacists Association (CAPA) Pharmacotherapy Symposium, Wellington, New Zealand.

Toop, L. (2014, March). Risk assessment is just the beginning of a conversation. Verbal presentation at the Population Health in Primary Care Symposium: Best Practice & Innovation, Wellington, New Zealand.

Savage, R. (2014, August). Varenicline and abnormal sleep-related events. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

O'Malley, C., Baker, M., Malloy, T., Toop, L., & Thomson, F. (2014, July). What does the roll out of the Government's Integrated Performance and Incentive Framework mean for GPs? Panel discussion at the Royal New Zealand College of General Practitioners (RNZCGP) Conference for General Practice: Making Connections: Are You Plugged In? Christchurch, New Zealand.

Toop, L. (2014, October). Are federations the future? Case study from New Zealand. Plenary presentation at the Royal College of General Practitioners Annual Primary Care Conference: Future Proof? Resilience in Practice, Liverpool, UK.

Toop, L. (2014, October). Development of federations (New Zealand). Verbal presentation at the Royal College of General Practitioners Annual Primary Care Conference: Future Proof? Resilience in Practice, Liverpool, UK.

Toop, L. (2014, August). Contemporary issues in cardiovascular risk assessment. Verbal presentation at the South General Practice Conference & Medical Exhibition (GP CME), Dunedin, New Zealand.